2023-06-13T15:18:34-04:00 2022-12-31 251644159 BROWN SCHULTZ SHERIDAN & FRITZ 7420 HAYWARD ROAD SUITE 101 FREDERICK MD 21702 990 2022-01-01 521214782 IMMUNE DEFICIENCY FOUNDATION IMMU 4103216647 7550 TEAGUE ROAD SUITE 220 HANOVER MD 21706 JOREY BERRY PRESIDENT & CEO 4103216647 2023-05-24 true JOREY BERRY XXX-XX-XXXX true WANDA K LYNN CPA P00726749 3016969449 2023-06-13 2022 2023-04-26 12:10:37Z X JOREY BERRY 7550 TEAGUE ROAD SUITE 220 HANOVER MD 21076 17534180 false X WWW.PRIMARYIMMUNE.ORG X 1980 DE THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITIY OF LIFE OF PEOPLE AFFECTED BY PRIMARY IMMUNODEFICIENCY THROUGH FOSTERING A COMMUNITY EMPOWERED BY ADVOCACY, EDUCATION, AND RESEARCH. 14 13 44 250 0 9152968 8654145 68746 785503 129557 0 9938471 8852448 69977 158570 0 3562638 4283731 0 1156100 4391000 3494170 8023615 7936471 1914856 915977 14287227 14567941 444776 1525931 13842451 13042010 X THE IMMUNE DEFICIENCY FOUNDATION (IDF) IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF PEOPLE AFFECTED BY PRIMARY IMMUNODEFICIENCY THROUGH FOSTERING A COMMUNITY EMPOWERED BY ADVOCACY, EDUCATION, AND RESEARCH. IDF SEEKS TO ENSURE THAT EVERYONE IN THE U.S. AFFECTED BY PI HAS A FULLY INFORMED UNDERSTANDING OF THE PI DIAGNOSIS THAT AFFECTS THEM, ALL AVAILABLE TREATMENT OPTIONS, THE EXPECTED STANDARD OF CARE, AND ALL OF THEIR OPPORTUNITIES FOR CONNECTION AND SUPPORT WITHIN THE PI COMMUNITY. false false 2591621 16450 IDF PROVIDED EDUCATIONAL PROGRAMS FOR PATIENTS AND FAMILIES LIVING WITH PRIMARY IMMUNODEFICIENCIES (PI). IN 2022, APPROXIMATELY 7,798 INDIVIDUALS ATTENDED MORE THAN 335 PRESENTATIONS. THESE INCLUDED IDF FORUMS AND EDUCATION MEETINGS, IDF GET CONNECTED GROUP MEETINGS, TEEN AND YOUNG ADULT ACTIVITIES, THE IDF PI CONFERENCE AND SCID COMPASS SUMMIT. MORE THAN 103,209 IDF EDUCATIONAL MATERIALS WERE DISTRIBUTED AND 881,747 USERS ACCESSED THE IDF WEBSITE FOR INFORMATION AND SUPPORT. 1078922 THE PRIMARY IMMUNODEFICIENCY COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE TO ANSWER INSURANCE QUESTIONS, LOCATE A SPECIALIST IN THEIR AREA, FIND INFORMATION ABOUT TREATMENT, AND LEARN MORE ABOUT THEIR DIAGNOSIS. IDF'S PATIENT ADVOCACY SPECIALISTS FULFILLED INFORMATION REQUESTS FROM MORE THAN 1,453 INDIVIDUALS SEEKING EDUCATION, INFORMATION, AND ASSISTANCE REGARDING OVER 1,890 TOPICS. IDF WORKS THROUGHOUT THE YEAR AT THE FEDERAL AND STATE LEVEL TO EDUCATE LAWMAKERS AND THE PUBLIC ABOUT ISSUES THAT IMPACT THE PI COMMUNITY. A STRONG VOLUNTEER GRASSROOTS ADVOCACY NETWORK WORKS TO EDUCATE POLICYMAKERS ABOUT ISSUES AFFECTING THOSE WITH PI. IN 2022 IDF SUCCEEDED IN SECURING A PERMANENT MEDICARE BENEFIT FOR THOUSANDS OF PI PATIENTS TO RECEIVE HOME IVIG AFTER TEN YEARS OF LEGISLATIVE ADVOCACY. AT IDF ADVOCACY DAY, 240 INDIVIDUALS MET WITH AND SENT MESSAGES TO MEMBERS OF CONGRESS TO ENSURE THAT PEOPLE WITH PI ARE ABLE TO LIVE HEALTHY AND PRODUCTIVE LIVES WITH EXCELLENT TREATMENT OPTIONS AND ACCESS TO THE MOST APPROPRIATE HEALTHCARE AVAILABLE. 950377 139020 55545 IN AN EFFORT TO IMPROVE THE DIAGNOSIS, TREATMENT, AND CARE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT 7 MEDICAL CONFERENCES, PROVIDING INFORMATION AND RESOURCES TO OVER 590 MEDICAL PROFESSIONALS, AND ADMINISTERING A CONSULTING IMMUNOLOGIST PROGRAM THAT ALLOWS PHYSICIANS TO CONSULT WITH AN EXPERT CLINICAL IMMUNOLOGIST ABOUT PATIENT-SPECIFIC QUESTIONS TO OBTAIN VALUABLE DIAGNOSTIC, TREATMENT, AND DISEASE MANAGEMENT INFORMATION. IDF CONDUCTS NATIONAL SURVEYS AND FOCUS GROUPS OF PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS, BUILDING A COLLECTION OF QUANTIFIABLE DATA RELATED TO PRIMARY IMMUNODEFICIENCIES. IN 2022, THERE WERE 4 ABSTRACTS ACCEPTED AND FEATURED AT NATIONAL MEDICAL CONFERENCES AND 10 MANUSCRIPTS PUBLISHED IN PEER REVIEW SCIENTIFIC JOURNALS, ALL USING USIDNET DATA. BECAUSE MEDICAL RESEARCH IS A PRIORITY, THE IDF RESEARCH GRANT PROGRAM FUNDED 4 RESEARCH GRANTS IN 2022 TOTALING OVER 140,000. 844498 3100 13201 OTHER SERVICES TO PATIENTS AND FAMILIES 844498 3100 13201 5465418 true true false true false false false false false true true false false true true true true false false false false false false false false false false true true true false false false false false false false false false false false false false false false false false true 38 0 true 44 true false false false false false false false false false false false false X 14 13 false false false false false false false true true false false true true true true true true true true false CA CO CT DC DE FL GA IL MA MD MI MN NC ND NH NJ NY OH PA RI TN VA WA WI X X X SARAH ROSE 4103216647 7550 TEAGUE RD SUITE 220 HANOVER MD 21076 JOREY BERRY PRESIDENT & 40.00 X X 215354 0 27790 SARAH ROSE CFO 40.00 X 134904 0 24854 TAMMY BLACK VP COMMUNICA 40.00 X 134742 0 15169 AIMEE SIMPSON VP INSTITUTI 40.00 X 132431 0 13974 LYNN ALBIZO VP PUBLIC PO 40.00 X 121346 0 23882 KATHY ANTILLA VP EDUCATION 40.00 X 117495 0 22160 CHRISTOPHER DUCKETT DIR OF TALEN 40.00 X 109265 0 28585 JASON ANGELOS TRUSTEE 1.00 X 0 0 0 PETE ATHERTON SEROC CHAIR 1.00 X X 0 0 0 JOEL BUCKBERG VICE CHAIR 1.00 X X 0 0 0 STEVE FIETEK FINANCE CHAI 1.00 X X 0 0 0 TERRY HALPER TRUSTEE 1.00 X 0 0 0 SETH KAUFMAN DEVELOPMENT 1.00 X X 0 0 0 KATE SULLIVAN MD MAC VICE-CHA 1.00 X 0 0 0 REBECCA BUCKLEY MD MAC CHAIR 1.00 X 0 0 0 JOHN SEYMOUR PHD TRUSTEE 1.00 X 0 0 0 TRACY A SHAW BOARD CHAIR 1.00 X X 0 0 0 JOHN SMITH TRUSTEE 1.00 X 0 0 0 HARPER SPERO TRUSTEE 1.00 X 0 0 0 SONIA VOHNOUT SECRETARY 1.00 X X 0 0 0 965537 156414 7 false true false THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 555 MISSION BLVD SOUTH SAN FRANCISCO CA 94158 CONSULTING 214966 RTI INTERNATIONAL 3040 EAST CORNWALLIS RD RESEARCH TRIANGLE PARK NC 27709 CONSULTING 206393 THE MT ROYAL PRINTING COMPANY 6310 BLAIR HILL LN BALTIMORE MD 21209 CONSULTING 181720 FAEGRE DRINKER BIDDLE & REATH LLP PO BOX 536777 PITTSBURGH PA 15253 PUBLIC POLICY 162049 IMPACT EDUCATION LLC 589 SKIPPACK PIKE SUITE 200 BLUE BELL PA 19422 CONSULTING 135009 6 976335 7677810 8654145 SURVEY INCOME 541700 55545 55545 OTHER INCOME 541900 13201 13201 68746 299863 299863 8511426 8641048 40684 -129622 -40684 -170306 -170306 8852448 68746 129557 X 135763 135763 22807 22807 402903 169983 198256 34664 3161073 1981879 622440 556754 95977 54475 28898 12604 347830 213900 75468 58462 275948 169748 58214 47986 68935 46248 15927 6760 21886 14823 4338 2725 331175 331175 64722 64722 1084149 1040195 19794 24160 52717 51898 819 97539 43868 3351 50320 265823 197275 28427 40121 267438 174657 60676 32105 98794 70294 4916 23584 386048 248382 17448 120218 1604 1604 149207 101058 29573 18576 38221 27455 6228 4538 DUES & SUBSCRIPTIONS 183938 144524 26040 13374 SUPPLIES 176127 109079 13561 53487 BANK FEES 63098 24295 6457 32346 TELEPHONE 62715 38820 15158 8737 80034 52817 13457 13760 7936471 5465418 1314953 1156100 689372 1250364 1849442 1536582 58271 430471 8920 167228 188115 241538 31001 70590 210537 10801889 10175769 278235 196186 943197 14287227 14567941 404082 306894 19864 63962 20830 1155075 444776 1525931 X 13249405 11721888 593046 1320122 13842451 13042010 14287227 14567941 915977 -1716418 X false true X true true true X 5305252 8943841 6486028 9152968 8654145 38542234 5305252 8943841 6486028 9152968 8654145 38542234 16795839 21746395 499810 329215 194897 286433 299863 1610218 1320 37061 38381 40190833 808013 0.54110 0.51120 X PART II, LINE 10 OTHER INCOME 38,381 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 174631 189740 364371 7571791 7936162 546808 136702 37929 true 580081 476627 551181 546808 2154697 3232046 227766 182043 225131 364371 999311 145020 119157 137795 136702 538674 808011 67906 74996 58108 174631 375641 6183528 1114253 -1099022 6198759 5483828 699700 6183528 4962050 521778 5483828 4140560 821490 4962050 4412670 -272110 4140560 1.00000 false false 213957 3420 210537 27581 27581 210537 RIGHT OF USE ASSET 926067 SECURITY DEPOSIT 17130 943197 OPERATING LEASES 1155075 1155075 X 7071308 -1716418 -1716418 8787726 64722 64722 8852448 7871749 7871749 64722 64722 7936471 SCHEDULE D, PAGE 3, PART X THE FOUNDATION IS INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE AS A NONPROFIT ORGANIZATION. THE FOUNDATION HAS ELECTED UNDER PROVISIONS OF INTERNAL REVENUE CODE (IRC) SECTION 501(C)(3) AND STATE INCOME TAX STATUTES TO BE EXCLUDED FROM TAXES ON EXCEPT FUNCTION INCOME. THEREFORE, NO PROVISION IS MADE FOR TAXES ON INCOME. THE FOUNDATION IS SUBJECT TO AN EXCISE TAX ON EXCESS LOBBYING EXPENDITURES UNDER IRC SECTION 4911. THE FOUNDATION'S TAX RETURNS FOR 2022, 2021, 2020, AND 2019 ARE SUBJECT TO EXAMINATION BY THE IRS AND STATE TAX AUTHORITIES GENERALLY FOR THREE YEARS AFTER THEY WERE FILED. THE FOUNDATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. true BAYLOR COLLEGE OF MEDICINE 1 BAYLOR PLAZA HOUSTON TX 77030 741613878 501C3 50000 RESEARCH CHILDREN'S HOSPITAL CORPORATION D/B/A BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501C3 40763 RESEARCH THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 972 BRUSH HOLLOW ROAD SUITE 5TH FLOOR WESTBURY NY 11590 112673595 501C3 25000 RESEARCH ALLERGY & IMMUNOLOGY CARE CENTER OF SOUTH FL LLC 16371 NORTHWEST 67TH AVENUE MIAMI LAKES FL 33014 821127569 10000 WHITE PAPER AWARD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501C3 10000 WHITE PAPER AWARD 4 1 HONORARIA 69 22807 SCHEDULE I, PAGE 1, PART I, LINE 2 EACH GRANT APPLICATION IS REVIEWED BY A COMMITTEE USING NIH SCORING CRITERIA. ONCE THE GRANT IS AWARDED, A 6-MONTH FINANCIAL AND PROGRESS REPORT IS DUE AS IS A 12-MONTH FINAL REPORT, WITH FINAL DELIVERABLES/ABSTRACT OR PUBLICATION DUE WITHIN 2 YEARS. X X X false false false false false false false false false JOREY BERRY PRESIDENT & CEO 215354 6636 21154 243144 SARAH ROSE CFO 134904 5648 19206 159758 FORM 990 - ORGANIZATION'S MISSION THE IMMUNE DEFICIENCY FOUNDATION (IDF) IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF PEOPLE AFFECTED BY PRIMARY IMMUNODEFICIENCY THROUGH FOSTERING A COMMUNITY EMPOWERED BY ADVOCACY, EDUCATION, AND RESEARCH. IDF SEEKS TO ENSURE THAT EVERYONE IN THE U.S. AFFECTED BY PI HAS A FULLY INFORMED UNDERSTANDING OF THE PI DIAGNOSIS THAT AFFECTS THEM, ALL AVAILABLE TREATMENT OPTIONS, THE EXPECTED STANDARD OF CARE, AND ALL OF THEIR OPPORTUNITIES FOR CONNECTION AND SUPPORT WITHIN THE PI COMMUNITY. FORM 990, PAGE 2, PART III, LINE 4B THE PRIMARY IMMUNODEFICIENCY COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE TO ANSWER INSURANCE QUESTIONS, LOCATE A SPECIALIST IN THEIR AREA, FIND INFORMATION ABOUT TREATMENT, AND LEARN MORE ABOUT THEIR DIAGNOSIS. IDF'S PATIENT ADVOCACY SPECIALISTS FULFILLED INFORMATION REQUESTS FROM MORE THAN 1,453 INDIVIDUALS SEEKING EDUCATION, INFORMATION, AND ASSISTANCE REGARDING OVER 1,890 TOPICS. IDF WORKS THROUGHOUT THE YEAR AT THE FEDERAL AND STATE LEVEL TO EDUCATE LAWMAKERS AND THE PUBLIC ABOUT ISSUES THAT IMPACT THE PI COMMUNITY. A STRONG VOLUNTEER GRASSROOTS ADVOCACY NETWORK WORKS TO EDUCATE POLICYMAKERS ABOUT ISSUES AFFECTING THOSE WITH PI. IN 2022 IDF SUCCEEDED IN SECURING A PERMANENT MEDICARE BENEFIT FOR THOUSANDS OF PI PATIENTS TO RECEIVE HOME IVIG AFTER TEN YEARS OF LEGISLATIVE ADVOCACY. AT IDF ADVOCACY DAY, 240 INDIVIDUALS MET WITH AND SENT MESSAGES TO MEMBERS OF CONGRESS TO ENSURE THAT PEOPLE WITH PI ARE ABLE TO LIVE HEALTHY AND PRODUCTIVE LIVES WITH EXCELLENT TREATMENT OPTIONS AND ACCESS TO THE MOST APPROPRIATE HEALTHCARE AVAILABLE. FORM 990, PAGE 2, PART III, LINE 4C IN AN EFFORT TO IMPROVE THE DIAGNOSIS, TREATMENT, AND CARE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT 7 MEDICAL CONFERENCES, PROVIDING INFORMATION AND RESOURCES TO OVER 590 MEDICAL PROFESSIONALS, AND ADMINISTERING A CONSULTING IMMUNOLOGIST PROGRAM THAT ALLOWS PHYSICIANS TO CONSULT WITH AN EXPERT CLINICAL IMMUNOLOGIST ABOUT PATIENT-SPECIFIC QUESTIONS TO OBTAIN VALUABLE DIAGNOSTIC, TREATMENT, AND DISEASE MANAGEMENT INFORMATION. IDF CONDUCTS NATIONAL SURVEYS AND FOCUS GROUPS OF PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS, BUILDING A COLLECTION OF QUANTIFIABLE DATA RELATED TO PRIMARY IMMUNODEFICIENCIES. IN 2022, THERE WERE 4 ABSTRACTS ACCEPTED AND FEATURED AT NATIONAL MEDICAL CONFERENCES AND 10 MANUSCRIPTS PUBLISHED IN PEER REVIEW SCIENTIFIC JOURNALS, ALL USING USIDNET DATA. BECAUSE MEDICAL RESEARCH IS A PRIORITY, THE IDF RESEARCH GRANT PROGRAM FUNDED 4 RESEARCH GRANTS IN 2022 TOTALING OVER 140,000. FORM 990, PAGE 2, PART III, LINE 4D OTHER SERVICES TO PATIENTS AND FAMILIES FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED BY THE CHIEF FINANCIAL OFFICER ONCE COMPLETED BY THE OUTSIDE CPA FIRM. ONCE THE CHIEF FINANCIAL OFFICER IS SATISFIED WITH THE ACCURACY, THE 990 IS THEN PASSED ON TO THE PRESIDENT & CEO FOR REVIEW. AFTER THAT LEVEL OF REVIEW IS COMPLETE, IT IS THEN PASSED ON TO THE FINANCE COMMITTEE FOR APPROVAL. ONCE THAT HAPPENS IT IS REVIEWED AND ONCE ACCURATE, APPROVED BY THE BOARD OF TRUSTEES. FORM 990, PAGE 6, PART VI, LINE 12C EACH YEAR IDF REQUESTS THAT ALL BOARD OF TRUSTEE MEMBERS AND STAFF COMPLETE A CONFLICT OF INTEREST STATEMENT DISCLOSING ANY POTENTIAL CONFLICT THAT MAY EXIST. THESE ARE KEPT ON FILE IN THE IDF OFFICE. THE BOARD LIAISON/CFO DISTRIBUTES THE STATEMENT ANNUALLY FOR SIGNATURES TO THE BOARD. THE BOARD LIAISON/CFO, WOULD DISTRIBUTE TO ANY STAFF NECESSARY. THE BOARD LIAISON/CFO WOULD REVIEW AND WOULD BRING IT TO THE PRESIDENT & CEO'S ATTENTION IS THERE ARE CONFLICTS. ANY RESTRICTIONS, IF NECESSARY, WOULD BE MADE AT HIS LEVEL OR ABOVE, DEPENDING ON WHO/WHAT THE CONFLICT IS. FORM 990, PAGE 6, PART VI, LINE 15A THE PRESIDENT & CEO'S COMPENSATION IS REVIEWED AND DOCUMENTED BY THE EXECUTIVE COMMITTEE. THE COMMITTEE REVIEWS WEBSITES SUCH AS SALARY.COM AND/OR REVIEWS OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK TO DETERMINE THE CORRECT SALARY FOR THE POSITION. THE COMPENSATION IS PRESENTED AND APPROVED BY THE FULL BOARD. THE EXECUTIVE COMMITTEE INFORMS THE PRESIDENT & CEO, HUMAN RESOURCES, AND ACCOUNTING. FOR ALL EMPLOYEES, AN ANNUAL REVIEW IS CONDUCTED BY THE EMPLOYEE'S SUPERVISOR. BASED ON THIS REVIEW, IT IS DETERMINED IF THE PERSON GETS AN ANNUAL INCREASE BEYOND THE COST OF LIVING. REVIEW OF WEBSITES SUCH AS SALARY.COM AND/OR REVIEW OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK HELPS DETERMINE THE CORRECT SALARY FOR THE POSITION. IF THE SUPERVISOR APPROVES AN INCREASE, PAPERWORK IS DRAWN UP AND SUBMITTED TO THE PRESIDENT & CEO FOR APPROVAL AND IS ALSO REVIEWED BY THE EXECUTIVE COMMITTEE. ONCE APPROVAL IS COMPLETE, HUMAN RESOURCES AND ACCOUNTING ARE INFORMED OF THE INCREASE. THE EMPLOYEE IS NOTIFIED AS WELL. FORM 990, PAGE 6, PART VI, LINE 15B THE PRESIDENT & CEO'S COMPENSATION IS REVIEWED AND DOCUMENTED BY THE PERSONNEL COMMITTEE. THE COMMITTEE REVIEWS WEBSITES SUCH AS SALARY.COM AND/OR REVIEWS OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK TO DETERMINE THE CORRECT SALARY FOR THE POSITION. THE COMPENSATION IS PRESENTED AND APPROVED BY THE FULL BOARD. THE PERSONNEL COMMITTEE INFORMS THE PRESIDENT & CEO, HUMAN RESOURCES, AND ACCOUNTING. FOR ALL EMPLOYEES, AN ANNUAL REVIEW IS CONDUCTED BY THE EMPLOYEE'S SUPERVISOR. BASED ON THIS REVIEW, IT IS DETERMINED IF THE PERSON GETS AN ANNUAL INCREASE BEYOND THE COST OF LIVING. REVIEW OF WEBSITES SUCH AS SALARY.COM AND/OR REVIEW OF MATERIALS SUCH AS ASAE'S COMPENSATION AND BENEFITS STUDY BOOK HELPS DETERMINE THE CORRECT SALARY FOR THE POSITION. IF THE SUPERVISOR APPROVES AN INCREASE, PAPERWORK IS DRAWN UP AND SUBMITTED TO THE PRESIDENT & CEO FOR APPROVAL AND IS ALSO REVIEWED BY THE PERSONNEL COMMITTEE. ONCE APPROVAL IS COMPLETE, HUMAN RESOURCES AND ACCOUNTING ARE INFORMED OF THE INCREASE. THE EMPLOYEE IS NOTIFIED AS WELL. FORM 990, PAGE 6, PART VI, LINE 17 NORTH DAKOTA, NEW HAMPSHIRE, NEW JERSEY, NEW YORK, OHIO, PENNSYLVANIA, RHODE ISLAND, TENNESSEE, VIRGINIA, WASHINGTON, WISCONSIN FORM 990, PAGE 6, PART VI, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE. FORM 990, PART IX, LINE 11G MEDICAL CONSULTANT 93,500 0 0 OTHER CONSULTING 946,695 19,794 24,160 TOTAL 1,040,195 19,794 24,160